Clinical Trials Directory

Trials / Completed

CompletedNCT01271127

Screening for Coronary Artery Disease After Mediastinal Irradiation

Screening for Coronary Artery Disease After Mediastinal Irradiation in Hodgkin Lymphoma Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Leiden University Medical Center · Academic / Other
Sex
All
Age
35 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Survivors of Hodgkin Lymphoma (HL) are known to have an increased risk of developing late treatment sequelae such as cardiovascular events due to coronary artery disease. At present no active screening is performed in these patients since it is not known whether screening and subsequent treatment by means of revascularization is effective in reducing the risk of cardiovascular events in symptomatic individuals. In the trial the efficacy and therapeutic consequences of screening for coronary artery diasease by multi-slice CT (MSCT) among asymptomatic HL survivors will be evaluated.

Detailed description

Objectives: 1. to determine whether MSCT as a screening method of HL survivors treated with mediastinal irradiation accurately identifies asymptomatic significant coronary artery disease. 2. to establish the prevelance of coronary abnormalities in HL survivors treated with mediastinal irradiation 3. to determine the frequency and type of intervention 4. to evaluate the acceptance of screening and asses quality of life among Hl survivors. Study polulation: 50 long term survivors of HL, previously treatef with mediastinal irradiation without present evidence of cardiovascular disease Intervention: CT-coronary angiography and calcium score, to be performed as a screening method (to indicate further diagnostic treatent procedures)

Conditions

Interventions

TypeNameDescription
RADIATIONCT coronary angiographypatient will undergo one CT coronary angiography

Timeline

Start date
2011-01-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2011-01-06
Last updated
2013-06-12

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01271127. Inclusion in this directory is not an endorsement.